Publications and Presentations
Pancreatic endocrine cell clusters derived from a non-pluripotent stem cell capable of regulating blood glucose in animal models of diabetesJ. Ratiu, S. Southard, W. Rust. October 23, 2023.
Novel Stem-Cell Derived Islets For Treating Diabetes (Poster 10117) William L. Rust, PhD, Pankaj M. Dalal, PhD, Anatoliy P. Koval, PhD, Jeremy J. Ratiu, PhD, Sheryl M. Southard, PhD, Paul S. Strumph, MD, and Carole A. Welsch, PhD, MBA. June 16, 2023.
Jacob, A., Southard, S. & Rust, W. Cell Replacement Therapy for Insulin-Dependent Diabetes: Maintaining Islet Architecture and Distribution After Graft. Curr Transpl Rep 7, 99–104 (2020).
Rust, W. Regenerative Medicine Technologies Applied to Beta Cell Replacement: The Industry Perspective. In: Orlando G, Piemonti L, Ricordi C, Stratta RJ, and Gruessner RWG, (eds). Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas, Volume 2. San Diego: Elsevier Inc./Academic Press, 2020.
Welsch CA, Rust WL, Csete M. Concise Review: Lessons Learned from Islet Transplant Clinical Trials in Developing Stem Cell Therapies for Type 1 Diabetes. Stem Cells Transl Med. 2018 Nov 12.
Rust, WL (2017, March). Stem Cell cure for insulin–dependent diabetes: dreams versus reality. CDI International Diabetes Summit, Pune, India.
Rust, WL (2017, October). Development of a cell replacement therapy for insulin dependent diabetes: achievements and remaining challenges. Stem Cell Symposium, Baltimore, Maryland, United States.
Southard, S, Kotipatruni, R, Rust, W (2017, October). Long-term function of stem cell grafts for insulin-dependent diabetes. Stem Cell Symposium, Baltimore, Maryland, United States.
Southard, S, Kotipatruni, R, Rust, WL. Generation and selection of pluripotent stem cells for robust differentiation to insulin-secreting cells capable of reversing diabetes in rodents. PLOS 2018; 13(9). doi: 10.1371/journal.pone.0203126